Nifty14,938.10-142.65

Aurobindo Pharma Ltd.

862.80-12.10 (-1.38%)
Volume: 17,92,630

Closed
Last Updated On: 05 Mar, 2021, 03:59 PM IST

OPEN TRADING A/C

TECHNICALS
COMPARE

Overview
News
Financials
Technicals
Peers
Shareholdings
MF
F&O
Corporate Actions
About
More
- F&O
- Corporate Actions
- About
Rank 72 - ET 5002020 ranking

Insights

View All

Intraday fact check
In the last 16 years, only 3.12 % trading sessions saw intraday declines higher than 5 % .
Employee & Interest Expense
Company has spent 1.32% of its operating revenues towards interest expenses and 13.94% towards employee cost in the year ending Mar 31, 2020. (Source: Consolidated Financials)
Sell Signal: Bearish trend in offing
5 day moving crossover appeared on Mar 04, 2021. Average price decline of -2.81% within 7 days of this signal in last 5 years.
Stock Returns vs Nifty 100
Stock gave a 3 year return of 42.33% as compared to Nifty 100 which gave a return of 42.14%. (as of last trading session)

InsightsAurobindo Pharma Ltd.

Intraday fact check
In the last 16 years, only 3.12 % trading sessions saw intraday declines higher than 5 % .
Employee & Interest Expense
Company has spent 1.32% of its operating revenues towards interest expenses and 13.94% towards employee cost in the year ending Mar 31, 2020. (Source: Consolidated Financials)
Sell Signal: Bearish trend in offing
5 day moving crossover appeared on Mar 04, 2021. Average price decline of -2.81% within 7 days of this signal in last 5 years.
Stock Returns vs Nifty 100
Stock gave a 3 year return of 42.33% as compared to Nifty 100 which gave a return of 42.14%. (as of last trading session)

Do you find these insights useful?

hate it
meh
love it

Key Metrics

PE Ratio
PE Ratio
This is a ratio arrived at by dividing the current market price of a stock by its latest (annual or annualized) earnings per share. Here we have taken the TTM (trailing twelve months) adjusted earnings per share.
(x)
9.39
EPS - TTM
EPS - TTM
Earnings per share (TTM) tells the profit after tax earned on a per share basis by a stock over the last twelve months or four quarters.
(₹)
91.87
MCap
MCap
MCap or Market capitalization of a stock is calculated by multiplying the total number of shares outstanding of that particular stock with its current market price.
(₹ Cr.)
50,587.01
Sectoral MCap Rank
Sectoral MCap Rank
This is the ranking of a company within its sector based on MCap or Market capitalization. Higher the market capitalization of a company, higher the rank it is assigned.
5
PB Ratio
PB Ratio
Price to Book represents the ratio of current market price of a stock to its book value per share. The book value itself is arrived at by dividing the net worth of a company by the total number of shares outstanding of the company at that time.
(x)
3.05
Div Yield
Dividend Yield
Dividend Yield calculates the amount of full year dividend declared by a company as a percentage of the current market price of a stock. All other things being equal, higher the dividend yield of the stock, the better it is for investors.
(%)
0.35
Face Value
Face Value
Face value of a stock is the value ascribed to the stock as per the balance sheet of the company. The dividend declared by a company is usually declared as a percentage of face value.
(₹)
1.00
Beta
Beta
1 Month 1.73
3 Months 1.31
6 Months 0.82
1 Year 1.06
3 Years 1.23
1.73
VWAP
VWAP
Volume Weighted Average Price represents the average price of a security over a particular time period (example one trading day) weighted by the volume traded at each price point.
(₹)
862.81
52W H/L
52W H/L
This represents the 52 week high and low price of the security. It is also the 1 year high and low of the security. This represents the highest and lowest price touched by the security during the past 52 weeks or 1 year including today.
(₹)
1,023.70 / 288.85
BV/Share
BV/Share
Book value represents the value arrived at by subtracting the total liabilities from the total assets of the company. On dividing this value with the total number of shares outstanding for the company, we can arrive at book value per share. Book value is also known as Net Asset Value of a company.
(₹)
286.90
MCap/Sales
MCap/Sales
This is a ratio of market capitalisation of a company’s stock to its annual sales. The market capitalization here is taken for the fully paid-up equity share of the company.
1.05
- 52W H/L
- BV/Share
- MCap/Sales

PE Ratio
PE Ratio
This is a ratio arrived at by dividing the current market price of a stock by its latest (annual or annualized) earnings per share. Here we have taken the TTM (trailing twelve months) adjusted earnings per share.
(x)
9.39
EPS - TTM
EPS - TTM
Earnings per share (TTM) tells the profit after tax earned on a per share basis by a stock over the last twelve months or four quarters.
(₹)
91.87
MCap
MCap
MCap or Market capitalization of a stock is calculated by multiplying the total number of shares outstanding of that particular stock with its current market price.
(₹ Cr.)
50,581.15
Sectoral MCap Rank
Sectoral MCap Rank
This is the ranking of a company within its sector based on MCap or Market capitalization. Higher the market capitalization of a company, higher the rank it is assigned.
5
PB Ratio
PB Ratio
Price to Book represents the ratio of current market price of a stock to its book value per share. The book value itself is arrived at by dividing the net worth of a company by the total number of shares outstanding of the company at that time.
(x)
3.05
Div Yield
Dividend Yield
Dividend Yield calculates the amount of full year dividend declared by a company as a percentage of the current market price of a stock. All other things being equal, higher the dividend yield of the stock, the better it is for investors.
(%)
0.35
Face Value
Face Value
Face value of a stock is the value ascribed to the stock as per the balance sheet of the company. The dividend declared by a company is usually declared as a percentage of face value.
(₹)
1.00
Beta
Beta
1 Month 1.72
3 Months 1.30
6 Months 0.82
1 Year 1.06
3 Years 1.24
1.72
VWAP
VWAP
Volume Weighted Average Price represents the average price of a security over a particular time period (example one trading day) weighted by the volume traded at each price point.
(₹)
-
52W H/L
52W H/L
This represents the 52 week high and low price of the security. It is also the 1 year high and low of the security. This represents the highest and lowest price touched by the security during the past 52 weeks or 1 year including today.
(₹)
1,023.10 / 281.15
BV/Share
BV/Share
Book value represents the value arrived at by subtracting the total liabilities from the total assets of the company. On dividing this value with the total number of shares outstanding for the company, we can arrive at book value per share. Book value is also known as Net Asset Value of a company.
(₹)
286.90
MCap/Sales
MCap/Sales
This is a ratio of market capitalisation of a company’s stock to its annual sales. The market capitalization here is taken for the fully paid-up equity share of the company.
1.05
- 52W H/L
- BV/Share
- MCap/Sales

Key Metrics

PE Ratio
PE Ratio
This is a ratio arrived at by dividing the current market price of a stock by its latest (annual or annualized) earnings per share. Here we have taken the TTM (trailing twelve months) adjusted earnings per share.
(x)
9.39
EPS - TTM
EPS - TTM
Earnings per share (TTM) tells the profit after tax earned on a per share basis by a stock over the last twelve months or four quarters.
(₹)
91.87
Dividend Yield
Dividend Yield
Dividend Yield calculates the amount of full year dividend declared by a company as a percentage of the current market price of a stock. All other things being equal, higher the dividend yield of the stock, the better it is for investors.
(%)
0.35
VWAP
VWAP
Volume Weighted Average Price represents the average price of a security over a particular time period (example one trading day) weighted by the volume traded at each price point.
(₹)
862.81
PB Ratio
PB Ratio
Price to Book represents the ratio of current market price of a stock to its book value per share. The book value itself is arrived at by dividing the net worth of a company by the total number of shares outstanding of the company at that time.
(x)
3.05
MCap
MCap
MCap or Market capitalization of a stock is calculated by multiplying the total number of shares outstanding of that particular stock with its current market price.
(₹ Cr.)
50,587.01
Face Value
Face Value
Face value of a stock is the value ascribed to the stock as per the balance sheet of the company. The dividend declared by a company is usually declared as a percentage of face value.
(₹)
1.00
BV/Share
BV/Share
Book value represents the value arrived at by subtracting the total liabilities from the total assets of the company. On dividing this value with the total number of shares outstanding for the company, we can arrive at book value per share. Book value is also known as Net Asset Value of a company.
(₹)
286.90
Sectoral MCap Rank
Sectoral MCap Rank
This is the ranking of a company within its sector based on MCap or Market capitalization. Higher the market capitalization of a company, higher the rank it is assigned.
5
52W H/L
52W H/L
This represents the 52 week high and low price of the security. It is also the 1 year high and low of the security. This represents the highest and lowest price touched by the security during the past 52 weeks or 1 year including today.
(₹)
1,023.70 / 288.85
Beta
Beta
1 Month 1.73
3 Months 1.31
6 Months 0.82
1 Year 1.06
3 Years 1.23
1.73
MCap/Sales
MCap/Sales
This is a ratio of market capitalisation of a company’s stock to its annual sales. The market capitalization here is taken for the fully paid-up equity share of the company.
1.05

PE Ratio
PE Ratio
This is a ratio arrived at by dividing the current market price of a stock by its latest (annual or annualized) earnings per share. Here we have taken the TTM (trailing twelve months) adjusted earnings per share.
(x)
9.39
EPS - TTM
EPS - TTM
Earnings per share (TTM) tells the profit after tax earned on a per share basis by a stock over the last twelve months or four quarters.
(₹)
91.87
Dividend Yield
Dividend Yield
Dividend Yield calculates the amount of full year dividend declared by a company as a percentage of the current market price of a stock. All other things being equal, higher the dividend yield of the stock, the better it is for investors.
(%)
0.35
VWAP
VWAP
Volume Weighted Average Price represents the average price of a security over a particular time period (example one trading day) weighted by the volume traded at each price point.
(₹)
-
PB Ratio
PB Ratio
Price to Book represents the ratio of current market price of a stock to its book value per share. The book value itself is arrived at by dividing the net worth of a company by the total number of shares outstanding of the company at that time.
(x)
3.05
MCap
MCap
MCap or Market capitalization of a stock is calculated by multiplying the total number of shares outstanding of that particular stock with its current market price.
(₹ Cr.)
50,581.15
Face Value
Face Value
Face value of a stock is the value ascribed to the stock as per the balance sheet of the company. The dividend declared by a company is usually declared as a percentage of face value.
(₹)
1.00
BV/Share
BV/Share
Book value represents the value arrived at by subtracting the total liabilities from the total assets of the company. On dividing this value with the total number of shares outstanding for the company, we can arrive at book value per share. Book value is also known as Net Asset Value of a company.
(₹)
286.90
Sectoral MCap Rank
Sectoral MCap Rank
This is the ranking of a company within its sector based on MCap or Market capitalization. Higher the market capitalization of a company, higher the rank it is assigned.
5
52W H/L
52W H/L
This represents the 52 week high and low price of the security. It is also the 1 year high and low of the security. This represents the highest and lowest price touched by the security during the past 52 weeks or 1 year including today.
(₹)
1,023.10 / 281.15
Beta
Beta
1 Month 1.72
3 Months 1.30
6 Months 0.82
1 Year 1.06
3 Years 1.24
1.72
MCap/Sales
MCap/Sales
This is a ratio of market capitalisation of a company’s stock to its annual sales. The market capitalization here is taken for the fully paid-up equity share of the company.
1.05

Returns

1 Day-1.38%
1 Week0.89%
1 Month-8.49%
3 Months-4.2%
1 Year63.75%
3 Years43.62%
5 Years23.04%

Aurobindo Pharm News & Analysis

View all News & Announcements

Recommendations

No Recent Recos Available

View Past Recommendations

Financials

Income (P&L)
Balance Sheet
Cash Flow
Ratios

Insights

Employee & Interest Expense
Company has spent 1.32% of its operating revenues towards interest expenses and 13.94% towards employee cost in the year ending Mar 31, 2020. (Source: Consolidated Financials)

Quarterly \| Annual	Dec 2020	Sep 2020	Jun 2020	Mar 2020	Dec 2019
Total Income	6,498.31	6,537.19	6,040.37	6,191.02	5,925.93
Total Income Growth (%)	-0.59	8.22	-2.43	4.47	5.42
Total Expenses	2,458.96	5,307.97	4,922.95	5,062.37	4,950.01
Total Expenses Growth (%)	-53.67	7.82	-2.75	2.27	4.95
EBIT	4,039.35	1,229.22	1,117.42	1,128.65	975.92
EBIT Growth (%)	228.61	10.01	-0.99	15.65	7.86
Profit after Tax (PAT)	2,946.46	806.23	780.58	849.83	705.45
PAT Growth (%)	265.46	3.29	-8.15	20.47	10.25
EBIT Margin (%)	62.16	18.80	18.50	18.23	16.47
Net Profit Margin (%)	45.34	12.33	12.92	13.73	11.90
Basic EPS (₹)	50.29	13.75	13.32	14.50	12.04

Quarterly \| Annual	Dec 2020	Sep 2020	Jun 2020	Mar 2020	Dec 2019
Total Income	3,875.83	4,572.96	3,545.28	3,780.93	3,383.65
Total Income Growth (%)	-15.24	28.99	-6.23	11.74	3.94
Total Expenses	2,857.74	3,437.34	2,574.66	2,890.58	2,813.04
Total Expenses Growth (%)	-16.86	33.51	-10.93	2.76	3.86
EBIT	1,018.09	1,135.62	970.62	890.35	570.61
EBIT Growth (%)	-10.35	17.00	9.02	56.03	4.33
Profit after Tax (PAT)	740.51	801.54	714.68	725.04	419.07
PAT Growth (%)	-7.61	12.15	-1.43	73.01	5.26
EBIT Margin (%)	26.27	24.83	27.38	23.55	16.86
Net Profit Margin (%)	19.11	17.53	20.16	19.18	12.39
Basic EPS (₹)	12.64	13.68	12.20	12.37	7.15

Quarterly \| Annual	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Total Revenue	23,290.38	19,718.87	16,565.01	15,025.43	13,998.45
Total Revenue Growth (%)	18.11	19.04	10.25	7.34	14.58
Total Expenses	19,506.04	16,542.16	13,326.97	11,969.61	11,255.60
Total Expenses Growth (%)	17.92	24.13	11.34	6.34	12.00
Profit after Tax (PAT)	2,830.97	2,364.73	2,423.17	2,301.66	2,025.09
PAT Growth (%)	19.72	-2.41	5.28	13.66	28.51
Operating Profit Margin (%)	17.70	17.58	20.14	20.94	21.74
Net Profit Margin (%)	12.25	12.08	14.71	15.43	14.68
Basic EPS (₹)	48.32	40.36	41.36	39.33	34.67

Quarterly \| Annual	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Total Revenue	13,669.85	12,457.11	10,350.55	9,743.00	9,354.54
Total Revenue Growth (%)	9.74	20.35	6.24	4.15	14.61
Total Expenses	11,292.15	10,492.49	8,007.61	7,564.43	7,206.70
Total Expenses Growth (%)	7.62	31.03	5.86	4.96	15.83
Profit after Tax (PAT)	1,872.74	1,529.73	1,812.77	1,706.76	1,626.70
PAT Growth (%)	22.42	-15.61	6.21	4.92	7.28
Operating Profit Margin (%)	19.73	17.91	23.32	23.14	25.93
Net Profit Margin (%)	14.11	12.47	17.65	17.76	17.74
Basic EPS (₹)	31.96	26.11	30.94	29.16	27.85

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Total Assets	28,926.35	26,454.36	21,101.04	16,249.42	15,920.20
Total Assets Growth (%)	9.34	25.37	29.86	2.07	23.27
Total Liabilities	12,115.83	12,561.99	9,418.80	6,875.43	8,630.35
Total Liabilities Growth (%)	-3.55	33.37	36.99	-20.33	11.61
Total Equity	16,810.52	13,892.37	11,682.24	9,373.99	7,289.85
Total Equity Growth (%)	21.01	18.92	24.62	28.59	40.68
Current Ratio (x)	1.44	1.28	1.41	1.39	1.31
Total Debt to Equity (x)	0.32	0.49	0.38	0.33	0.61
Contingent Liabilities	659.39	688.84	716.95	849.78	539.66

Annual	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Total Assets	19,534.57	18,140.72	15,793.84	13,022.92	12,565.56
Total Assets Growth (%)	7.68	14.86	21.28	3.64	22.88
Total Liabilities	6,509.01	6,790.10	5,811.26	4,586.74	5,699.71
Total Liabilities Growth (%)	-4.14	16.84	26.70	-19.53	17.13
Total Equity	13,025.56	11,350.62	9,982.58	8,436.18	6,865.85
Total Equity Growth (%)	14.76	13.70	18.33	22.87	28.11
Current Ratio (x)	1.77	1.55	1.56	1.55	1.45
Total Debt to Equity (x)	0.29	0.40	0.37	0.34	0.55
Contingent Liabilities	2,174.36	2,736.18	1,480.23	838.92	3,022.44

All figures in Rs Cr, unless mentioned otherwise

View Details

Insights

Decrease in Cash from Investing
Company has used Rs 1567.64 cr for investing activities which is an YoY decrease of 45.99%. (Source: Consolidated Financials)

Annual	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Net Cash flow from Operating Activities	4,381.28	1,650.97	1,954.52	3,278.58	1,419.76
Net Cash used in Investing Activities	-1,567.64	-2,902.59	-1,926.59	-1,787.04	-1,445.21
Net Cash flow from Financing Activities	-1,947.18	1,919.06	864.15	-1,915.26	365.44
Net Cash Flow	871.24	665.64	891.91	-423.86	339.99
Closing Cash & Cash Equivalent	2,746.82	1,875.58	1,209.94	319.63	743.80
Closing Cash & Cash Equivalent Growth (%)	46.45	55.01	278.54	-57.03	65.08
Total Debt/ CFO (x)	1.24	4.09	2.29	0.94	3.11

Annual	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Net Cash flow from Operating Activities	2,161.73	529.89	922.40	2,457.20	1,185.18
Net Cash used in Investing Activities	-921.57	-1,297.36	-990.60	-1,542.05	-1,390.11
Net Cash flow from Financing Activities	-1,252.39	599.40	439.69	-1,328.99	514.97
Net Cash Flow	-9.26	-171.25	371.49	-413.84	310.04
Closing Cash & Cash Equivalent	59.44	68.70	239.95	-129.94	283.90
Closing Cash & Cash Equivalent Growth (%)	-13.48	-71.37	-284.66	-145.77	2,450.76
Total Debt/ CFO (x)	1.73	8.53	3.96	1.17	3.17

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Return on Equity (%)	16.84	17.02	20.74	24.55	27.78
Return on Capital Employed (%)	23.31	23.82	26.66	32.37	37.12
Return on Assets (%)	9.78	8.93	11.48	14.16	12.72
Interest Coverage Ratio (x)	13.40	13.10	42.66	46.80	11.69
Asset Turnover Ratio (x)	79.85	73.95	78.01	91.75	86.64
Price to Earnings (x)	8.55	19.49	13.48	17.21	21.55
Price to Book (x)	1.44	3.32	2.80	4.22	5.98
EV/EBITDA (x)	5.30	12.38	9.26	11.87	13.92
EBITDA Margin (%)	21.88	20.99	23.52	23.81	24.58

Annual	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Return on Equity (%)	14.37	13.47	18.15	20.23	23.69
Return on Capital Employed (%)	19.87	19.25	23.86	25.92	32.91
Return on Assets (%)	9.58	8.43	11.47	13.10	12.94
Interest Coverage Ratio (x)	10.87	9.51	45.30	49.24	10.37
Asset Turnover Ratio (x)	67.91	67.57	65.02	73.77	72.94
Price to Earnings (x)	12.94	30.12	18.02	23.20	26.81
Price to Book (x)	1.86	4.06	3.27	4.69	6.35
EV/EBITDA (x)	9.02	19.36	13.11	16.89	17.81
EBITDA Margin (%)	23.28	21.28	26.78	26.12	28.80

Financial InsightsAurobindo Pharma Ltd.

Income (P&L)
Cash Flow

- Employee & Interest Expense
  Company has spent 1.32% of its operating revenues towards interest expenses and 13.94% towards employee cost in the year ending Mar 31, 2020. (Source: Consolidated Financials)
- Decrease in Cash from Investing
  Company has used Rs 1567.64 cr for investing activities which is an YoY decrease of 45.99%. (Source: Consolidated Financials)

Do you find these insights useful?

hate it
meh
love it

Technicals

Buy / Sell Signals
Price Analysis
Pivot Levels & ATR
Chart

Bullish / Bearish signals for Aurobindo Pharma Ltd. basis selected technical indicators and moving average crossovers.
5 Day EMA Crossover
Bearish signal on daily chart
Appeared on: 4 Mar 2021
5D EMA: 875.80
Last 4 Sell Signals:11 Feb 2021
Date 7 days Gain/Loss %
11 Feb 2021 -2.69%
28 Jan 2021 -5.88%
15 Jan 2021 -5.97%
13 Jan 2021 -1.94%
Average price decline of -2.80% within 7 days of Bearish signal in last 5 years
10 Day EMA Crossover
Bearish signal on daily chart
Appeared on: 3 Mar 2021
10D EMA: 881.44
Last 4 Sell Signals:11 Feb 2021
Date 7 days Gain/Loss %
11 Feb 2021 -2.69%
28 Jan 2021 -5.88%
15 Jan 2021 -5.97%
21 Dec 2020 -2.88%
Average price decline of -3.08% within 7 days of Bearish signal in last 5 years
44%
Positive Movement since
1st Jan 2005 on basis
55%
Negative Movement since
1st Jan 2005 on basis
Exclude
Global Meltdown - 1st Jan 2008 to 10th Nov 2008
Covid Crisis - 1st Feb 2020 to 31st Mar 2020
Pivot Levels
R1 R2 R3 PIVOT S1 S2 S3
Classic 873.17 883.53 902.48 864.58 854.22 845.63 826.68
Average True Range
5 DAYS 14 DAYS 28 DAYS
ATR 21.11 26.27 28.87

Date	7 days Gain/Loss %
11 Feb 2021	-2.69%
28 Jan 2021	-5.88%
15 Jan 2021	-5.97%
13 Jan 2021	-1.94%

Date	7 days Gain/Loss %
11 Feb 2021	-2.69%
28 Jan 2021	-5.88%
15 Jan 2021	-5.97%
21 Dec 2020	-2.88%

	R1	R2	R3	PIVOT	S1	S2	S3
Classic	873.17	883.53	902.48	864.58	854.22	845.63	826.68

	5 DAYS	14 DAYS	28 DAYS
ATR	21.11	26.27	28.87

Peer Comparison

Stock Performance
Ratio Performance

CHART
TABLE

Insights

Stock Returns vs Nifty 100
Stock gave a 3 year return of 42.33% as compared to Nifty 100 which gave a return of 42.14%. (as of last trading session)
Stock Returns vs Nifty Pharma
Stock generated 42.33% return as compared to Nifty Pharma which gave investors 38.82% return over 3 year time period. (as of last trading session)

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Aurobindo Pharm	-1.38	0.89	-8.49	-4.20	63.75	43.62	23.04
Dr. Reddys	-1.80	1.49	-6.42	-8.48	41.08	106.00	38.11
Cipla	-0.20	2.30	-5.02	4.98	82.74	39.00	49.74
Biocon	-1.29	1.13	-3.09	-10.86	26.09	26.62	386.62
Lupin	-1.45	1.46	-3.42	10.71	52.72	30.77	-41.96
Add More

Insights

Stock Returns vs Nifty 100
Stock gave a 3 year return of 42.33% as compared to Nifty 100 which gave a return of 42.14%. (as of last trading session)
Stock Returns vs Nifty Pharma
Stock generated 42.33% return as compared to Nifty Pharma which gave investors 38.82% return over 3 year time period. (as of last trading session)

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Aurobindo Pharm	9.39	3.01	16.84	23.31	9.78	15.56	17.70	12.31	48.32	1.44	0.32	1.24
Dr. Reddys	34.34	4.79	12.98	12.04	8.72	7.99	11.00	11.24	122.22	1.75	0.11	0.60
Cipla	29.02	4.04	9.81	12.32	6.53	6.06	13.86	9.02	19.19	2.66	0.18	0.92
Biocon	77.54	6.41	11.15	11.61	5.18	17.08	19.03	14.13	6.32	1.33	0.28	1.47
Lupin	40.90	3.72	-2.14	11.85	-1.07	-3.15	12.15	-1.78	-5.95	1.67	0.34	2.92
Add More

Annual Ratios (%)

Choose from Peers

Cadila Health
Torrent Pharma
Gland Pharma
Alkem Lab
Ipca Labs

Choose from Stocks

See All Parameters

Peers InsightsAurobindo Pharma Ltd.

Stock Returns vs Nifty 100
Stock gave a 3 year return of 42.33% as compared to Nifty 100 which gave a return of 42.14%. (as of last trading session)
Stock Returns vs Nifty Pharma
Stock generated 42.33% return as compared to Nifty Pharma which gave investors 38.82% return over 3 year time period. (as of last trading session)

Do you find these insights useful?

hate it
meh
love it

Shareholding Pattern

QOQ Change
Total Shareholdings

Showing Shareholding as on 31 Dec 2020

Category	31 Dec 2020	30 Sep 2020	30 Jun 2020	31 Mar 2020
Promoters	51.94	52.01	52.01	52.01
Pledge	9.27	9.34	6.17	6.17
FII	27.45	25.48	22.63	22.26
DII	10.15	11.19	12.56	12.56
Mutual Funds	9.94	11.02	12.20	11.95
Others	10.46	11.32	12.80	13.17

Showing Shareholding as on 31 Dec 2020

Category	No. of Shares	Percentage	% Change QoQ
Promoters	30,43,15,471	51.94 %	-0.07
Pledge	2,82,24,000	9.27 %	-0.07
FII	16,08,48,365	27.45 %	1.97
DII	5,94,41,153	10.15 %	-1.04
MF	5,82,56,966	9.94 %	-1.08
Others	6,13,33,620	10.46 %	-0.86

MF Ownership

HDFC Hybrid Equity Direct-G
Hybrid: Aggressive Hybrid
3
- 579.36
  Amount Invested (in Cr.)
- 3.49%
  % of AUM
- -4.48
  % Change (MoM basis)
HDFC Mid-Cap Opportunities Direct-G
Equity: Mid Cap
3
- 492.54
  Amount Invested (in Cr.)
- 2.05%
  % of AUM
- 0.00
  % Change (MoM basis)
Nippon India Pharma Direct-G
Equity: Sectoral-Pharma
- 452.62
  Amount Invested (in Cr.)
- 10.78%
  % of AUM
- 0.00
  % Change (MoM basis)

MF Ownership as on 31 January 2021

View all Schemes

F&O Quote

Futures
Options

- Expiry
Price
879.90-7.20 (-0.81%)
Open High Low Prev Close Contracts Traded Turnover (₹ Lakhs)
881.05 889.50 872.55 887.10 2,628 15,071.76

Open	High	Low	Prev Close	Contracts Traded	Turnover (₹ Lakhs)
881.05	889.50	872.55	887.10	2,628	15,071.76

Corporate Actions

Board Meeting/AGM
Dividends
Others

Meeting Date	Announced on	Purpose	Details
Feb 10, 2021	Feb 01, 2021	Board Meeting	Quarterly Results & Interim Dividend
Nov 11, 2020	Nov 02, 2020	Board Meeting	Quarterly Results & Interim Dividend
Aug 27, 2020	Aug 03, 2020	AGM	Book closure from 25 Aug, 2020 to 27 Aug, 2020
Aug 12, 2020	Aug 05, 2020	Board Meeting	Quarterly Results & Interim Dividend
Jun 03, 2020	May 27, 2020	Board Meeting	Audited Results

Type	Dividend	Dividend per Share	Ex-Dividend Date	Announced on
Interim	150%	1.5	Feb 22, 2021	Feb 10, 2021
Interim	125%	1.25	Nov 23, 2020	Nov 11, 2020
Interim	125%	1.25	Aug 21, 2020	Aug 12, 2020
Interim	175%	1.75	Feb 17, 2020	Feb 06, 2020
Interim	125%	1.25	Nov 21, 2019	Nov 13, 2019

All Types	Ex-Date	Record Date	Announced on	Details
Bonus	Jul 20, 2015	Jul 21, 2015	May 28, 2015	Bonus Ratio: 1 share(s) for every 1 shares held
Splits	Feb 10, 2011	Feb 11, 2011	Nov 03, 2010	Split: Old FV5.0\| New FV:1.0
Splits	Oct 23, 2003	Oct 31, 2003	Aug 09, 2003	Split: Old FV10.0\| New FV:5.0
Bonus	Mar 07, 2000	Apr 01, 2000	Feb 22, 2000	Bonus Ratio: 1 share(s) for every 1 shares held
Bonus	Oct 26, 1998	Nov 19, 1998	Oct 08, 1998	Bonus Ratio: 1 share(s) for every 1 shares held

About Aurobindo Pharm

Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 50,554.78 Crore) operating in Pharmaceuticals sector. Aurobindo Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Export Incentives, Sale of services and Scrap for the year ending 31-Mar-2020. Show More

Executives
Auditors

AB
Avnit Bimal Singh
Ind. Non-Executive Director
BA
B Adi Reddy
Co. Secretary & Compl. Officer
KN
K Nithyananda Reddy
Vice Chairman & Whole Time Dir
KR
K Ragunathan
Non Executive Chairman
MM
M Madan Mohan Reddy
Whole Time Director
MS
M Sitarama Murthy
Ind. Non-Executive Director
MS
M Sivakumaran
Whole Time Director
NG
N Govindarajan
Managing Director
PS
P Sarath Chandra Reddy
Whole Time Director
PV
P V Ramprasad Reddy
Non Executive Director
SS
Santhanam Subramanian
Chief Financial Officer
SM
Savita Mahajan
Ind. Non-Executive Director
Show More
BSR & Associates LLP

Industry

Pharma - Indian

Key Indices Listed on

Nifty Next 50, Nifty 100, Nifty 200, + 23 more

Address

Plot No.2,Maitri Vihar,Ameerpet,Hyderabad, Telangana - 500038

Contact

info@aurobindo.com

http://www.aurobindo.com

More Details

Aurobindo Pharm Share Price Update

Aurobindo Pharma Ltd. share price moved down by -1.38% from its previous close of Rs 874.90. Aurobindo Pharma Ltd. stock last traded price is 862.80

Share Price	Value
Today/Current/Last	862.80862.60
Previous Day	874.90874.50

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.

BrowseCompanies:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

1 2 3 4 5 6 7 8 9

Aurobindo Pharma Ltd.